Akebia Therapeutics
AKBA
#6758
Rank
A$0.77 B
Marketcap
$2.98
Share price
-3.73%
Change (1 day)
31.19%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$0.97

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.05. In 2022 the company made an earnings per share (EPS) of -$0.84 an increase over its 2021 EPS that were of -$2.79.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.9715.57%
2022-$0.84-70%
2021-$2.79-38.63%
2020-$4.5517.37%
2019-$3.882.79%
2018-$3.7731.2%
2017-$2.88-51.39%
2016-$5.9257.89%
2015-$3.75-94.83%
2014-$72.52589.75%
2013-$10.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$23.26-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.15-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$23.16-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.68 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA